Identification of key components in the irreversibility of salmon calcitonin binding to calcitonin receptors
Open accessThe DOI matches its Crossref record; 41 of the 42 references it cites were found in a registry or an index.
Abstract
This study investigates the poor reversibility of salmon calcitonin (sCT) binding to rat and human calcitonin receptors. Efficacy of CT and analogue peptides in (125)I-sCT binding competition and cAMP assays was compared with the dissociation kinetics of (125)I-labelled peptides. Assessment was performed on cells stably expressing either rat or human calcitonin receptors. Dissociation kinetics of the antagonists, sCT(8-32) and AC512, revealed that binding was rapidly and completely reversible at the receptors, despite high affinity binding, suggesting that poor reversibility required the active conformation of the receptor. G protein coupling was not essential as the dissociation kinetics of (125)I-sCT binding to cell membranes did not significantly alter in the presence of GTP gamma S. Time course experiments established that the transition to irreversibility was slow, while the reversible component of binding appeared to involve a single population of either receptor states or binding sites. Pre-bound (125)I-human CT dissociated rapidly from the receptors, indicating that not all agonists bound irreversibly. To identify structural features of sCT that contribute to its poor reversibility, dissociation kinetics of sCT analogues with various structural modifications were examined. Increasing truncation of N-terminal residues of sCT analogues led to a corresponding increase in the rate of peptide dissociation. Salmon CT peptides which had been substituted at the N-terminus by 13-21 residues of human CT (hCT) were equipotent with sCT in binding competition and cAMP accumulation assays but exhibited a dissociation rate similar to hCT. In contrast, despite lower affinity and efficacy at the receptors, the chimeric analogue sCT(1-16)-hCT(17-32) displayed poorly reversible binding, similar to sCT. Analysis of the dissociation kinetics of sCT analogues with differing alpha-helix forming potential indicated that the ability to form alpha-helical secondary structure was an important factor in the rate of ligand dissociation. We hypothesise that poor reversibility results from a conformational change in the receptor and/or ligand and that this is dependent, at least in part, on interaction with residues constrained within the alpha-helix of the peptide.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In structure/function studies, chimeras of sCT and hCT were made, and sCT peptides, which had the NH 2 terminus substituted by the 13-21 residues of hCT, completely dissociated from receptors, whereas combinations of sCT (1-16) and hCT (17)(18)(19)(20)(21)(22)(23)(24)(25)(26)(27)(28)(29)(30)(31)(32) retained the irreversible binding of sCT (92).”
From The Activity of Peptides of the Calcitonin Family in Bone (2019) · cites this paper as [92]
Citations
Cites
Biochemical and Biophysical Research Communications
(1960) · Nature · doi:10.1038/186124d0 · Cited by 6,700
Nicholson, G. C., Moseley, J. M., Sexton, P. M., Mendelsohn, F. A., & Martin, T. J. (1986) · Journal of Clinical Investigation · doi:10.1172/jci112584 · Cited by 454 · cited 3×
“…of sCT, sCT analogues and sCT/hCT chimeras Synthetic sCT, sCT analogues and sCT/hCT chimeric peptides were iodinated as previously described (Nicholson et al. 1986), with 125I using 5 µg chloramine T for 10 s as oxidant, purification with the silica resin QUSO G32 (North America Silica Co.,…”
BackgroundMethodInfluentialSelf-citationGorn, A. H., Lin, H. Y., Yamin, M., Auron, P. E., Flannery, M. R., Tapp, D. R., Manning, C. A., Lodish, H. F., Krane, S. M., & Goldring, S. R. (1992) · Journal of Clinical Investigation · doi:10.1172/jci116046 · Cited by 211 · cited 4×
“Calcitonin receptors (CTRs) have been cloned from a number of species including rat (Sexton et al. 1993) and human (Gorn et al. 1992, Kuestner et al. 1994).”
BackgroundMethodInfluentialBisello, A., Adams, A. E., Mierke, D. F., Pellegrini, M., Rosenblatt, M., Suva, L. J., & Chorev, M. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.35.22498 · Cited by 181 · cited 1×
“It has been speculated that the -helical secondary structure adopted by family B G protein coupled receptor ligands may be important in orienting the ligand into phase with the binding site(s) of the receptor (Bisello et al. 1998).”
BackgroundFull Activation of Chimeric Receptors by Hybrids between Parathyroid Hormone and Calcitonin
Bergwitz, C., Gardella, T. J., Flannery, M. R., Potts, J. T., Kronenberg, H. M., Goldring, S. R., & Jüppner, H. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.43.26469 · Cited by 169 · cited 1×
“Chimeric peptide/receptor studies between sCT and PTH and their receptors, have revealed a similar mode of ligand–receptor interaction for these peptides (Bergwitz et al. 1996).”
BackgroundCloning and characterization of an abundant subtype of the human calcitonin receptor.
Kuestner, R. E., Elrod, R. D., Grant, F. J., Hagen, F. S., Kuijper, J. L., Matthewes, S. L., O'Hara, P. J., Sheppard, P. O., Stroop, S. D., & Thompson, D. L. (1994) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)09678-6 · Cited by 149 · cited 7×
“G protein coupling was not essential as the dissociation kinetics of 125I-sCT binding to cell membranes did not significantly alter in the presence of GTP S. Time course experiments established that the transition to irreversibility was slow, while the reversible component of binding appeared to…”
BackgroundMethodInfluentialIdentification of brain isoforms of the rat calcitonin receptor.
Sexton, P. M., Houssami, S., Hilton, J. M., O'Keeffe, L. M., Center, R. J., Gillespie, M. T., Darcy, P., & Findlay, D. M. (1993) · Molecular Endocrinology · doi:10.1210/mend.7.6.8395656 · Cited by 134 · cited 3×
“In rat, the principle receptor isoforms, C1a and C1b, differ by the absence or presence, respectively, of a 37 amino acid insert in the predicted second extracellular domain (Sexton et al. 1993).”
BackgroundSelf-citationCharacterization and regional distribution of calcitonin binding sites in the rat brain
Fischer, J. A., Sagar, S. M., & Martin, J. B. (1981) · Life Sciences · doi:10.1016/0024-3205(81)90018-7 · Cited by 107 · cited 4×
“This is true of human or rat tissue membrane preparations ( Fischer et al. 1981, Nicholson et al. 1988b), as well as clonal cell lines of rat or human origin (Findlay et al. 1981, Chao & Forte 1983).”
BackgroundResultInfluentialOffermanns, S. (1996) · Molecular Endocrinology · doi:10.1210/me.10.5.566 · Cited by 106 · cited 2×
“This is particularly true for release of intracellular calcium, presumably mediated by coupling to Gq (Offermanns et al. 1996), as no signal was seen in insert-positive receptor (Moore et al.”
BackgroundMoore, E. E. (1995) · Molecular Endocrinology · doi:10.1210/me.9.8.959 · Cited by 104 · cited 9×
“Analysis of the function of the I1 insert demonstrates that while ligand recognition remains essentially unchanged, G protein-mediated signalling is markedly impaired (Moore et al. 1995).”
BackgroundMethodInfluentialSelf-citationGorn, A. H., Rudolph, S. M., Flannery, M. R., Morton, C. C., Weremowicz, S., Wang, T. Z., Krane, S. M., & Goldring, S. R. (1995) · Journal of Clinical Investigation · doi:10.1172/jci117970 · Cited by 100 · cited 2×
“In contrast, despite lower affinity and efficacy at the receptors, the chimeric analogue sCT(1–16)-hCT(17–32) displayed poorly reversible binding, similar to sCT. Analysis of the dissociation kinetics of sCT analogues with differing -helix forming potential indicated that the ability to form…”
BackgroundIsoforms of the rat calcitonin receptor: consequences for ligand binding and signal transduction
Houssami, S. (1994) · Endocrinology · doi:10.1210/en.135.1.183 · Cited by 95 · cited 12×
“Levels of cAMP were then assayed using a specific radioimmunoassay, as described previously (Houssami et al. 1994b).”
BackgroundMethodInfluentialSelf-citationChimeric Human Calcitonin and Glucagon Receptors Reveal Two Dissociable Calcitonin Interaction Sites
Stroop, S. D., Kuestner, R. E., Serwold, T. F., Chen, L., & Moore, E. E. (1995) · Biochemistry · doi:10.1021/bi00003a040 · Cited by 93 · cited 1×
“However, the primary site of interaction for the peptides is likely to reside in the transmembrane domain and extracellular loop regions of the receptor as this is sufficient (at least for hCTR chimeras) to enable activation of the receptor (Stroop et al. 1995, 1996).”
BackgroundAlbrandt, K., Brady, E. M., Moore, C. X., Mull, E., Sierzega, M. E., & Beaumont, K. (1995) · Endocrinology · doi:10.1210/endo.136.12.7588285 · Cited by 88 · cited 2×
“In contrast, despite lower affinity and efficacy at the receptors, the chimeric analogue sCT(1–16)-hCT(17–32) displayed poorly reversible binding, similar to sCT. Analysis of the dissociation kinetics of sCT analogues with differing -helix forming potential indicated that the ability to form…”
BackgroundCentral nervous system binding sites for calcitonin and calcitonin gene-related peptide
Sexton, P. M. (1991) · Molecular Neurobiology · doi:10.1007/bf02935550 · Cited by 87
Self-citation25 Years of salmon calcitonin: From synthesis to therapeutic use
Azria, M., Copp, D. H., & Zanelli, J. M. (1995) · Calcified Tissue International · doi:10.1007/bf00301940 · Cited by 85
Conformational flexibility and biological activity of salmon calcitonin
Epand, R. M., Epand, R. F., Orlowski, R. C., Seyler, J. K., & Colescott, R. L. (1986) · Biochemistry · doi:10.1021/bi00356a019 · Cited by 71 · cited 1×
“It has been suggested that interaction occurs between the amino terminus of sCT and other parts of the ligand (Epand et al. 1986).”
BackgroundStroop, S. D. (1996) · Endocrinology · doi:10.1210/en.137.11.4752 · Cited by 64 · cited 5×
“…chimeric receptors and analogues with differing capacities to form -helical secondary structure (equivalent to those used in the current study), Stroop et al. (1996) demonstrated that the helical portion of the molecule is primarily responsible for binding to the N-terminal extracellular…”
BackgroundMethodInfluentialSILIGARDI, G., SAMORÍ, B., MELANDRI, S., VISCONTI, M., & DRAKE, A. F. (1994) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1994.tb18832.x · Cited by 56 · cited 1×
“The 8–16 region of sCT is capable of generating an amphipathic -helix (Siligardi et al. 1994) and circular dichroism analysis indicates that S16HCT adopted a similar degree of -helical secondary structure to sCT in aqueous conditions.”
BackgroundWada, S. (1995) · Endocrinology · doi:10.1210/en.136.6.2611 · Cited by 55
Localization and characterization of renal calcitonin receptors by in vitro autoradiography
Sexton, P. M., Adam, W. R., Moseley, J. M., Martin, T. J., & Mendelsohn, F. A. O. (1987) · Kidney International · doi:10.1038/ki.1987.287 · Cited by 55 · cited 1×
“In kidney, CT modulates calcium and magnesium excretion, while in the brain central actions include analgesia, appetite suppression and modulation of hormone release (Sexton et al. 1987, Sexton 1991).”
BackgroundSelf-citationTwo-dimensional NMR and structure determination of salmon calcitonin in methanol
Meadows, R. P., Nikonowicz, E. P., Jones, C. R., Bastian, J. W., & Gorenstein, D. G. (1991) · Biochemistry · doi:10.1021/bi00219a012 · Cited by 54 · cited 1×
“Furthermore, serine, threonine and asparagine residues, which are enriched in the loop region, have been shown to act as stabilisers of the N-terminus of an -helix (Meadows et al. 1991).”
BackgroundInternational Journal of Peptide and Protein Research
(2010) · International journal of peptide & protein research · doi:10.1111/(issn)1399-3011a · Cited by 54
Houssami, S., Findlay, D. M., Brady, C. L., Martin, T. J., Epand, R. M., Moore, E. E., Murayama, E., Tamura, T., Orlowski, R. C., & Sexton, P. M. (1995) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)08628-6 · Cited by 52 · cited 6×
“We previously reported that C-terminal residues (16– 32) of sCT are important for high affinity interaction with rat or human CTRs (Houssami et al. 1995).”
BackgroundInfluentialSelf-citationEpand, R. M., Epand, R. F., & Orlowski, R. C. (1985) · International journal of peptide & protein research · doi:10.1111/j.1399-3011.1985.tb02152.x · Cited by 48 · cited 1×
“c Epand et al. (1985) . Aib, amino isobutyric acid; For, formyl; Ip, isopropyl; Ac, N-terminal acetylation.”
Calcitonin receptor down-regulation relates to calcitonin resistance in mature mouse osteoclasts.
Wada, S., Udagawa, N., Nagata, N., Martin, T. J., & Findlay, D. M. (1996) · Endocrinology · doi:10.1210/endo.137.3.8603572 · Cited by 47 · cited 2×
“Recent data suggests that this is likely to be due to the rapid and sustained down-regulation of CTRs and CTR mRNA in osteoclasts, an action which is cAMP dependent (Wada et al. 1996a,b).”
BackgroundWada, S. (1996) · Endocrinology · doi:10.1210/en.137.1.312 · Cited by 45 · cited 2×
“Recent data suggests that this is likely to be due to the rapid and sustained down-regulation of CTRs and CTR mRNA in osteoclasts, an action which is cAMP dependent (Wada et al. 1996a,b).”
BackgroundEvidence for Calcitonin Receptor Heterogeneity: Binding Studies with Nonhelical Analogs*
NAKAMUTA, H., ORLOWSKI, R. C., & EPAND, R. M. (1990) · Endocrinology · doi:10.1210/endo-127-1-163 · Cited by 43
N-terminal truncation of salmon calcitonin leads to calcitonin antagonists
Feyen, J. H. M., CARDINAUX, F., Gamse, R., Bruns, C., Azria, M., & Trechsel, U. (1992) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(05)81450-0 · Cited by 41 · cited 1×
“Salmon CT peptides lacking the N-terminal 7 or 8 amino acids present as antagonists, while peptides intermediate in length between 1–32 and 9–32 exhibit a progression from full agonist to partial agonist to antagonist (Feyen et al. 1992).”
BackgroundMcArdle, C. A., Poch, A., Schomerus, E., & Kratzmeier, M. (1994) · Endocrinology · doi:10.1210/endo.134.6.7515005 · Cited by 37 · cited 1×
“…there have been few detailed studies on ligand–receptor binding kinetics for other members of the family B G protein coupled receptors, poor reversibility of agonist ligands has been observed with glucagon, PACAP and PTH/PTHrP receptors (Mitchell et al. 1990, Post et al. 1993, McArdle et al. 1994).”
BackgroundFindlay, D. M., Ng, K. W., Niall, M., & Martin, T. J. (1982) · Biochemical Journal · doi:10.1042/bj2060343 · Cited by 30 · cited 1×
“The down-regulation of cell surface receptors in these cells is independent of the generation of second messenger, and for poorly reversible CTR agonists termination of signalling is thought to involve internalisation of the ligand–receptor complex (Findlay et al. 1982, 1996).”
BackgroundMitchell, J., Rouleau, M. F., & Goltzman, D. (1990) · Endocrinology · doi:10.1210/endo-126-5-2327 · Cited by 29 · cited 2×
“Although there have been few detailed studies on ligand–receptor binding kinetics for other members of the family B G protein coupled receptors, poor reversibility of agonist ligands has been observed with glucagon, PACAP and PTH/PTHrP receptors ( Mitchell et al. 1990, Post et al. 1993, McArdle et al. 1994).”
BackgroundPost, S. R., Rubinstein, P. G., & Tager, H. S. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.5.1662 · Cited by 27
INDEPENDENT DOWN-REGULATION OF INSULIN AND CALCITONIN RECEPTORS ON A HUMAN TUMOUR CELL LINE
Findlay, D. M., Luise, M. D., Michelangeli, V. P., & Martin, T. J. (1981) · Journal of Endocrinology · doi:10.1677/joe.0.0880271 · Cited by 26 · cited 2×
“…earlier observations, which demonstrated that ‘irreversibility’ of 125I-sCT binding was independent of the system of assay, occurring in whole cells (Findlay et al. 1981, Chao & Forte 1983), membranes (Fischer et al. 1981, Nicholson et al. 1988b) and solubilised receptor (Nicholson et al. 1988a)…”
BackgroundMichelangeli, V. P., Findlay, D. M., Moseley, J. M., & Martin, T. J. (1983) · PubMed · Cited by 23
Biologically active calcitonin analogs which have minimal interactions with phospholipids
Epand, R. M., Epand, R. F., & Orlowski, R. C. (1988) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(88)80700-9 · Cited by 21
Rat Kidney Cells in Primary Culture: Interaction of Salmon Calcitonin with Receptor Sites*
Chao, W.-T. H., & Forte, L. R. (1983) · Endocrinology · doi:10.1210/endo-112-2-745 · Cited by 18 · cited 2×
“This is true of human or rat tissue membrane preparations (Fischer et al. 1981, Nicholson et al. 1988b), as well as clonal cell lines of rat or human origin (Findlay et al. 1981, Chao & Forte 1983).”
BackgroundRecent advances in our understanding of peptide hormone receptors and RAMPS.
Sexton, P. M. (1999) · PubMed · Cited by 12
Self-citationSolubilization of functional calcitonin receptors
Nicholson, G. C., D’Santos, C. S., Evans, T., Moseley, J. M., Kemp, B. E., & Martin, T. J. (1988) · Biochemical Journal · doi:10.1042/bj2530505 · Cited by 9 · cited 4×
“Poor reversibility is also maintained in solubilised receptor preparations (Nicholson et al. 1988a).”
BackgroundResultInfluentialFindlay, D. M., Houssami, S., Christopoulos, G., & Sexton, P. M. (1996) · Endocrinology · doi:10.1210/endo.137.11.8895320 · Cited by 9 · cited 3×
“The down-regulation of cell surface receptors in these cells is independent of the generation of second messenger, and for poorly reversible CTR agonists termination of signalling is thought to involve internalisation of the ligand–receptor complex (Findlay et al. 1982, 1996).”
BackgroundSelf-citationStructure/Activity Relationship of Chimeric Calcitonins
Sasaki, J., Matsumura, Y., Murayama, E., & Ohba, M. (1995) · Peptide chemistry : proceedings of the ... Symposium on Peptide Chemistry · Cited by 1
Cited by
Poyner, D. R., Sexton, P. M., Marshall, I., Smith, D. M., Quirion, R., Born, W., Muff, R., Fischer, J. A., & Foord, S. M. (2002) · Pharmacological Reviews · doi:10.1124/pr.54.2.233 · Cited by 804
“Although 125I-human CT binds reversibly to its receptor, salmon CT binds irreversibly, resulting in sustained cAMP accumulation (Fischer et al., 1981; Nicholson et al., 1987; Hilton et al., 2000).”
BackgroundSelf-citationPhase-plate cryo-EM structure of a class B GPCR–G-protein complex
Liang, Y.-L., Khoshouei, M., Radjainia, M., Zhang, Y., Glukhova, A., Tarrasch, J., Thal, D. M., Furness, S. G. B., Christopoulos, G., Coudrat, T., et al. (2017) · Nature · doi:10.1038/nature22327 · Cited by 462
“Nonspecific binding was measured in the presence of 1 μM of [8-32]sCT.”
BackgroundMethodSelf-citationAmylin: Pharmacology, Physiology, and Clinical Potential
Hay, D. L., Chen, S., Lutz, T. A., Parkes, D. G., & Roth, J. D. (2015) · Pharmacological Reviews · doi:10.1124/pr.115.010629 · Cited by 400
“This is not surprising, given that it contains portions of the salmon calcitonin sequence; salmon calcitonin is well recognized as having a slow receptor dissociation rate from receptors (Hilton et al., 2000).”
BackgroundAdvances in therapeutic peptides targeting G protein-coupled receptors
Davenport, A. P., Scully, C. C. G., de Graaf, C., Brown, A. J. H., & Maguire, J. J. (2020) · Nature Reviews Drug Discovery · doi:10.1038/s41573-020-0062-z · Cited by 275
Dean, T., Vilardaga, J.-P., Potts, J. T., & Gardella, T. J. (2008) · Molecular Endocrinology · doi:10.1210/me.2007-0274 · Cited by 227
“Thus, several others of these receptors, including the receptors for calcitonin (34), CRH (17), and glucagon (35) have been shown to form a stable complex with their cognate peptide ligand in the presence of a nonhydrolyzable guanine nucleotide analog.”
Background
Metadata
- Authors
- Hilton, J., Dowton, M., Houssami, S., & Sexton, P.
- Affiliations
- The University of Melbourne (AU)
- ORCID
- Dowton, M
- Venue
- Journal of Endocrinology
- Publisher
- Bioscientifica
- Published
- 2000-07-01
- Volume
- 166
- Issue
- 1
- Pages
- 213-226
- ISSN
- 0022-0795 (ISSN-L)
- 1479-6805
- OpenAlex
- W2134691383
- Cited by
- 70
- References
- 42
- Citations by year
- 2025: 3 · 2024: 1 · 2022: 4 · 2021: 6 · 2020: 7 · 2019: 3 · 2018: 3 · 2017: 3 · 2016: 5 · 2015: 3 · 2014: 4 · 2013: 1 · 2012: 3
- FWCI
- 0.84
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Journal of Endocrinology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Amylin Pharmaceuticals
- Medical Research Council
- National Health and Medical Research Council
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Receptor Mechanisms and Signaling
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuropeptides and Animal Physiology
- Physical Sciences › Chemistry › Organic Chemistry › Chemical Synthesis and Analysis
- Keywords
- salmon calcitonin, calcitonin receptor, ligand dissociation kinetics, receptor conformational change, N-terminal truncation, alpha-helix, G protein coupling
- MeSH terms
- Cyclic AMP, Animals, Binding, Competitive, Calcitonin, Cells, Cultured, Humans, Protein Binding, Receptors, Calcitonin, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.